Charles N Landen Jr
Overview
Explore the profile of Charles N Landen Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez S, Dimastromatteo J, Landen Jr C, Kelly K
Cells
. 2021 Sep;
10(9).
PMID: 34571866
Cancer-specific plectin (CSP) is a pro-tumorigenic protein selectively expressed on the cell surface of major cancers, including ovarian cancer (OC). Despite its assessable localization, abundance, and functional significance, the therapeutic...
2.
Kamat A, Fletcher M, Gruman L, Mueller P, Lopez A, Landen Jr C, et al.
Clin Cancer Res
. 2021 Aug;
27(15):4455.
PMID: 34341060
No abstract available.
3.
Lazo J, Sharlow E, Cornelison R, Hart D, Llaneza D, Mendelson A, et al.
Biomolecules
. 2021 Jul;
11(7).
PMID: 34209460
High grade serous ovarian cancer (OvCa) frequently becomes drug resistant and often recurs. Consequently, new drug targets and therapies are needed. Bioinformatics-based studies uncovered a relationship between high Protein Tyrosine...
4.
Powell C, Littell R, Landen Jr C, Pramanik S, Hamilton I, Suh-Burgmann E
Gynecol Oncol
. 2020 Jan;
156(3):636-640.
PMID: 31918994
Objective: To assess the feasibility of a novel hysteroscopic catheter to collect fallopian tube cytologic samples and to correlate cytologic findings with histopathology. Methods: This was a prospective, multicenter, single-arm...
5.
Halder J, Kamat A, Landen Jr C, Han L, Lutgendorf S, Lin Y, et al.
Clin Cancer Res
. 2019 May;
25(10):3194.
PMID: 31092618
No abstract available.
6.
Emmings E, Mullany S, Chang Z, Landen Jr C, Linder S, Bazzaro M
Int J Mol Sci
. 2019 Jan;
20(1).
PMID: 30626133
Ovarian cancer is the leading cause of death from gynecologic malignancy in the Western world. This is due, in part, to the fact that despite standard treatment of surgery and...
7.
Fuh K, Vlad A, Landen Jr C
Gynecol Oncol
. 2016 May;
142(1):9-12.
PMID: 27181388
No abstract available.
8.
Erickson B, Kinde I, Dobbin Z, Wang Y, Martin J, Alvarez R, et al.
Obstet Gynecol
. 2014 Dec;
124(5):881-885.
PMID: 25437714
Objective: To investigate whether tumor cells could be detected in the vagina of women with serous ovarian cancer through TP53 analysis of DNA samples collected by placement of a vaginal...
9.
Bradley A, Zheng H, Ziebarth A, Sakati W, Branham-OConnor M, Blumer J, et al.
Carcinogenesis
. 2014 Jan;
35(5):1100-9.
PMID: 24379240
The E3 ubiquitin ligase EDD is overexpressed in recurrent, platinum-resistant ovarian cancers, suggesting a role in tumor survival and/or platinum resistance. EDD knockdown by small interfering RNA (siRNA) induced apoptosis...
10.